• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
Quilla NewsFinance & Technology
ENES

Pfizer raises full-year guidance and bets on cancer and weight-loss drugs

FinanceInternationalBarron's10 s readAI summary
Image: Barron's

Pfizer raised its full-year guidance after reporting its latest quarterly results, driven by growth in its non-Covid products and acquired medicines. The company frames this as its second act after the pandemic, with bets on oncology and weight-loss drugs.

Read the full story at Barron's

IASummary generated by artificial intelligence from a story by Barron's. It may contain errors: the original source prevails.

More flashes